T Rowe Price Grp (TROW) Stock News

T. Rowe Price (NYSE:TROW) has released the sixth episode of its investment podcast series "The Angle," featuring interviews with Carlyle Group's CEO Harvey Schwartz and Co-Founder David Rubenstein. The episode, hosted by T. Rowe Price's Head of Global Investments Eric Veiel, explores Carlyle's founding, private markets evolution, and leadership insights.

The discussion covers topics including private markets transformation, democratization of investments, and the creation of shareholder value. Previous episodes featured CEOs from prominent companies including GE Aerospace, The New York Times, Intuitive Surgical, NVIDIA, and ExxonMobil. The podcast is available on Spotify and Apple Podcasts.

T. Rowe Price (NYSE:TROW) announced its Q2 2025 financial results, with details available on their website. The company will host a webcast from 8:00 - 8:45 AM ET where CEO Rob Sharps and CFO Jen Dardis will discuss business performance and financial results.

The webcast will be accessible through the investor relations website, with supplemental materials being made available before the call. A replay will be provided after the event.

T. Rowe Price (NYSE:TROW), in collaboration with MIT Sloan and Stanford, has released a groundbreaking study on retirement investment preferences across age groups. The research reveals that investors over 50 show diverse equity allocation preferences, with the majority favoring 60-80% equity exposure, while 10% avoid equities entirely and 5% prefer all-equity portfolios.

The study found that only 26% of older investors maintained unchanged equity allocations between 2019-2024, compared to 46% of younger investors. Notably, 50% of investors aged 50+ increased their equity exposure, versus 34% of those aged 20-34, suggesting a more active approach to portfolio management near retirement.

T. Rowe Price (NASDAQ-GS: TROW) reported preliminary assets under management (AUM) of $1.68 trillion as of June 30, 2025. The firm experienced net outflows of $7.0 billion in June 2025, primarily due to timing of redemptions and client rebalancing.

For Q2 2025, net outflows totaled $14.9 billion, including $0.7 billion of manager-driven distributions. The company's AUM breakdown shows Equity at $839B, Fixed Income at $200B, Multi-asset at $583B, and Alternatives at $55B. Target date retirement portfolios reached $520 billion, up from $504B in May 2025.

T. Rowe Price (NASDAQ-GS: TROW) has launched two new active transparent equity ETFs: the T. Rowe Price Global Equity ETF (TGLB) and T. Rowe Price International Equity Research ETF (TIER). TGLB will focus on developed markets with 45-60 high-conviction investments, while TIER will hold 300-500 securities across developed and emerging markets excluding the US.

These additions bring T. Rowe Price's total active ETF offerings to 24 funds, including 18 equity and 6 fixed income ETFs. The funds aim to provide tax efficiency, competitive expense ratios, and intraday trading flexibility while leveraging T. Rowe Price's global research capabilities to outperform passive indexes.

Oak Hill Advisors (OHA) has been appointed as Administrative Agent and Lead Left Arranger for private senior debt financing supporting Montagu Private Equity's acquisition of Tyber Medical. The deal involves merging Tyber Medical with Montagu's portfolio companies Resolve Surgical Technologies and Intech Medical to create a comprehensive CDMO for orthopedic devices. The combined entity will offer end-to-end services including product development, manufacturing, and regulatory approval for advanced surgical systems. OHA, leveraging its extensive experience in CDMO investments, is a major holder in the new first lien facility. BMO Capital Markets participated as OHA's private credit joint venture partner, while Rothschild & Co acted as Montagu's financial advisor for the debt financing.

T. Rowe Price (NASDAQ-GS: TROW) has expanded its ETF lineup with three new active transparent equity ETFs trading on NASDAQ. The new offerings include the T. Rowe Price Financials ETF (TFNS), Health Care ETF (TMED), and Natural Resources ETF (TURF), each with an expense ratio of 0.44%. TFNS focuses on financial services companies with a 50-70 company portfolio, TMED targets healthcare innovation with 100-150 stocks, and TURF invests in natural resource companies with 60-80 securities. These additions bring T. Rowe Price's active ETF roster to 22 offerings, comprising 16 equity and 6 fixed income ETFs. The funds aim to provide long-term capital appreciation through sector exposure while offering ETF benefits like tax efficiency and intraday trading flexibility.

T. Rowe Price Group reported preliminary assets under management (AUM) of $1.62 trillion as of May 31, 2025, showing mixed results across different segments. The company experienced net outflows of $4.4 billion in May 2025. Equity assets increased to $806 billion from $767 billion in April, while fixed income assets slightly rose to $199 billion. Multi-asset portfolios grew to $566 billion from $545 billion, and alternatives remained stable at $53 billion. Target date retirement portfolios showed growth, reaching $504 billion compared to $485 billion in the previous month. Despite the monthly net outflows, total AUM increased from $1.563 trillion in April 2025.

T. Rowe Price (TROW) released its 2025 midyear investment outlook, highlighting significant shifts in the global financial landscape. The outlook emphasizes deglobalization trends, tariff-driven trade reconfiguration, and broader market opportunities beyond U.S. equities and mega-cap tech stocks. Key projections include slower global economic growth due to trade war impacts, a shift favoring value stocks and emerging markets, and above-target inflation in developed markets. The firm expects U.S.-China trade tensions to reduce economic growth in both nations, with global ripple effects. Fixed income markets face a regime change driven by trade policies and German fiscal expansion, while corporate bonds enter potential downturn with strong credit quality. T. Rowe Price suggests portfolio adjustments favoring inflation protection, international equities, and active management strategies in this volatile environment.